Pursuing new tools and capabilities in sample logistics, storage, and data analysis.
Applied Clinical Trials-10-01-2022
The benefits of working with an institutional biosafety committee in CGT research.
Integrated approaches can help enhance recruitment plans.
Approaches sponsors, CROs, and investigators can take from the DMD experience.
As activity in this space grows, so do the hurdles in moving these products forward.
Chamber of Commerce for Greater Philadelphia ranks city No. 2 overall for cell CGT hubs.
Survey results emphasize need for flexibility in strategies.
New EU clinical trial regulation places heavy importance on patient-submitted documents.
Cell and gene therapy space set to advance amid recent therapeutic innovation.
Click the title above for a link to open the Applied Clinical Trials October 2022 issue in an interactive PDF format.
Barbara Lopez Kunz, president, and global chief executive at DIA, discusses key themes on the current state of the clinical trials industry and its future.
Agency officials express associated concerns around clinical trial data reliability and quality.
Accelerating trends in clinical data are forcing changes in strategy.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
4
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
